Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Page 1
Antibody responses after BNT162b2 vaccination in Japanese geriatric intermediate care facilities.
Suita A, Ohfuji S, Kasamatsu A, Kondo K, Nakata H, Kita T, Deguchi A, Fujimoto M, Iba K, Sakamoto H, Iwasaka K, Sakamoto N, Sakamoto H, Yodoi Y, Kido Y, Nakagama Y, Konishi A, Mukai E, Matsumoto K, Matsuura T, Kase T, Kakeya H, Fukushima W, Hirota Y. Suita A, et al. Among authors: kita t. Vaccine X. 2023 Nov 22;15:100412. doi: 10.1016/j.jvacx.2023.100412. eCollection 2023 Dec. Vaccine X. 2023. PMID: 38161985 Free PMC article.
Incidence and risk factors for norovirus-related diarrhea in Japanese geriatric intermediate care facilities: A prospective cohort study.
Suita A, Ohfuji S, Fukushima W, Ito K, Kase T, Kondo K, Ishibashi M, Kumashiro H, Kawai S, Deguchi A, Nakata H, Iba K, Kita T, Kinugawa K, Hamada K, Fujimoto M, Furukawa Y, Sowa E, Nakazawa H, Hirota Y. Suita A, et al. Among authors: kita t. Geriatr Gerontol Int. 2023 Mar;23(3):179-187. doi: 10.1111/ggi.14539. Epub 2023 Jan 20. Geriatr Gerontol Int. 2023. PMID: 36669482
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry.
Yamaji K, Shiomi H, Morimoto T, Matsumura-Nakano Y, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Kato ET, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Domei T, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Investigators. Yamaji K, et al. JACC Asia. 2022 Apr 12;2(3):294-308. doi: 10.1016/j.jacasi.2021.12.012. eCollection 2022 Jun. JACC Asia. 2022. PMID: 36411876 Free PMC article.
Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings.
Yoneda T, Sone T, Koba H, Shibata K, Suzuki J, Tani M, Nishitsuji M, Nishi K, Kobayashi T, Shirasaki H, Araya T, Kita T, Kase K, Yamamura K, Terada N, Nishikawa S, Tambo Y, Kimura H, Kasahara K. Yoneda T, et al. Among authors: kita t. Clin Lung Cancer. 2022 Sep;23(6):467-476. doi: 10.1016/j.cllc.2022.03.008. Epub 2022 May 1. Clin Lung Cancer. 2022. PMID: 35618628
However, ICI monotherapy is still considered an important treatment option. Data on long-term progression-free survival (PFS) and OS in real-world settings are limited. ...
However, ICI monotherapy is still considered an important treatment option. Data on long-term progression-free survival (PFS) and OS …
Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases.
Kita T, Kitamura K. Kita T, et al. Hypertens Res. 2022 Mar;45(3):389-400. doi: 10.1038/s41440-021-00806-y. Epub 2022 Jan 6. Hypertens Res. 2022. PMID: 34992239 Free PMC article. Review.
These AM derivatives can be administered by subcutaneous injection at long-term intervals. Accordingly, these derivatives will reduce the inconvenience in use compared to that for native AM and expand the possible applications of AM for treating CVDs. ...
These AM derivatives can be administered by subcutaneous injection at long-term intervals. Accordingly, these derivatives will reduce …
Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells.
Kita T, Kadochi Y, Takahashi K, Fukushima K, Yamasaki E, Uemoto T, Hirane M, Fukushima N, Honoki K, Tsujiuchi T. Kita T, et al. Exp Cell Res. 2016 Mar 15;342(2):193-9. doi: 10.1016/j.yexcr.2016.03.008. Epub 2016 Mar 8. Exp Cell Res. 2016. PMID: 26968637
Next, to evaluate effects of GPR120 and GPR40 on cellular functions induced by anti-cancer drug, the long-term cisplatin (CDDP) treated (A549-CDDP) cells were generated. The expression levels of GPR120 and GPR40 were significantly decreased in A549-CDDP cells. ...
Next, to evaluate effects of GPR120 and GPR40 on cellular functions induced by anti-cancer drug, the long-term cisplatin (CDDP) treat …
Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease.
Yamashita S, Masuda D, Ohama T, Arai H, Bujo H, Kagimura T, Kita T, Matsuzaki M, Saito Y, Fukushima M, Matsuzawa Y; PROSPECTIVE Study Group. Yamashita S, et al. Among authors: kita t. J Atheroscler Thromb. 2016 Jun 1;23(6):746-56. doi: 10.5551/jat.32813. Epub 2016 Jan 22. J Atheroscler Thromb. 2016. PMID: 26803913 Free PMC article. Clinical Trial.
SUMMARY: PROSPECTIVE will determine whether the addition of probucol to other lipid-lowering drugs improves cerebro- and cardiovascular outcomes in patients with prior coronary heart disease. Furthermore, the safety of a long-term treatment with probucol will be clarified. …
SUMMARY: PROSPECTIVE will determine whether the addition of probucol to other lipid-lowering drugs improves cerebro- and cardiovascular outc …
Clinical efficacy of thrombus aspiration on 5-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention.
Watanabe H, Shiomi H, Nakatsuma K, Morimoto T, Taniguchi T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO‐Kyoto AMI investigators; Kimura T, Sakata R, Marui A, Matsuda M, Mitsuoka H, Onoe M, Nakagawa Y, Yamanaka K, Fujiwara H, Takatsu Y, Ohno N, Nohara R, Murakami T, Takeda T, Nobuyoshi M, Iwabuchi M, Hanyu M, Tatami R, Matsushita T, Shirotani M, Nishiwaki N, Kita T, Furukawa Y, Okada Y, Kato H, Eizawa H, Is K, Tanaka M, Nakayama S, Lee JD, Nakano A, Koshiji T, Morioka K, Takizawa A, Shimamoto M, Yamazaki F, Takahashi M, Nishizawa J, Horie M, Takashima H, Tamura T, Aota M, Takahashi M, Tabata T, Tei C, Hamasaki S, Imoto Y, Yamamoto H, Kambara H, Doi O, Matsuda K, Nara M, Mitsudo K, Kadota K, Komiya T, Miki S, Mizoguchi T, Nakajima H, Ogawa H, Sugiyama S, Kawasuji M, Moriyama S, Hattori R, Aoyama T, Araki M, Suwa S, Tanbara K, Kitagawa K, Yamauchi M, Okamoto N, Fujino Y, Tezuka S, Saeki A, Hanazawa M, Sato Y, Hibi C, Sasae H, Takinami E, Uchida Y, Yamamoto Y, Nishida S, Yoshimoto M, Maeda S, Miki I, Minematsu S, Abe M, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Tokushige A, Natsuaki M, Nakajima T. Watanabe H, et al. Among authors: kita t. J Am Heart Assoc. 2015 Jun 15;4(6):e001962. doi: 10.1161/JAHA.115.001962. J Am Heart Assoc. 2015. PMID: 26077588 Free PMC article.
BACKGROUND: Adjunctive thrombus aspiration (TA) during primary percutaneous coronary intervention (PCI) was reported to promote better coronary and myocardial reperfusion. However, long-term mortality benefit of TA remains controversial. The objective of this study is to i …
BACKGROUND: Adjunctive thrombus aspiration (TA) during primary percutaneous coronary intervention (PCI) was reported to promote better coron …
Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.
Watanabe H, Morimoto T, Natsuaki M, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kastrati A, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Watanabe H, et al. Among authors: kita t. PLoS One. 2015 Apr 8;10(4):e0124314. doi: 10.1371/journal.pone.0124314. eCollection 2015. PLoS One. 2015. PMID: 25853836 Free PMC article.
This study is aimed to evaluate the risk of ischemic event after APT discontinuation based on long-term APT status of large cohort. In the CREDO-Kyoto Registry Cohort-2 enrolling 15939 consecutive patients undergoing first coronary revascularization, 10470 patients underwe …
This study is aimed to evaluate the risk of ischemic event after APT discontinuation based on long-term APT status of large cohort. I …
Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy.
Masuko K, Wakita D, Togashi Y, Kita T, Kitamura H, Nishimura T. Masuko K, et al. Among authors: kita t. Immunol Lett. 2015 Jan;163(1):102-12. doi: 10.1016/j.imlet.2014.11.016. Epub 2014 Dec 3. Immunol Lett. 2015. PMID: 25479286
The elevated vaccine efficacy of OVAH/K-HELP might be derived from the following mechanisms: (i) selective presentation by only professional dendritic cells (DC) in vaccinated draining lymph node (dLN); (ii) a long-term sustained antigen presentation exerted by DC to stimu …
The elevated vaccine efficacy of OVAH/K-HELP might be derived from the following mechanisms: (i) selective presentation by only professional …
77 results